[
    "{\"step_by_step_thinking\": \"Yes, tocilizumab has been assessed against Covid-19. There are multiple documents that discuss the use of tocilizumab in the treatment of severe and critical Covid-19 patients. These documents mention the potential benefits of tocilizumab in reducing mortality, improving clinical and laboratory parameters, and mitigating the cytokine storm associated with severe Covid-19. Some studies also highlight the importance of early administration of tocilizumab for better outcomes. However, there are also documents that mention the lack of definitive evidence and the need for further randomized controlled trials to confirm the efficacy and safety of tocilizumab in Covid-19. Overall, the available evidence suggests that tocilizumab has been assessed as a potential treatment for Covid-19.\", \"answer_choice\": \"A\"}"
]